Home Tech ICT

Qisda-backed Elixiron tackles Alzheimer's with new drug developments

Rebecca Kuo, Taipei; Kevin Wang, DIGITIMES Asia Monday 12 January 2026 0

Credit: DIGITIMES

Biotechnology firm Elixiron Immunotherapeutics is the only company in Asia to have twice received "Part the Cloud" grants sponsored by the US-based Alzheimer's Association and Bill Gates, securing roughly NT$60 million (US$1.9 million) in non-dilutive...

The article requires paid subscription. Subscribe Now

Email address

Password

Save my User ID and Password

Save my User ID and Password

Some subscribers prefer to save their log-in information so they do not have to enter their User ID and Password each time they visit the site. To activate this function, check the 'Save my User ID and Password' box in the log-in section. This will save the password on the computer you're using to access the site.

Note: If you choose to use the log-out feature, you will lose your saved information. This means you will be required to log-in the next time you visit our site.

NEW individual users please REGISTER first.

Enterprise user first-time LOGIN.

I forgot my ID and/or password?

MEMBERSHIP BENEFITS